LB Bohle – 10.06.2025
Nipro Vialex – 26th January 2025
PCI – 7th June 2024
Temax_Krautz

Current Edition

Nasal & Pulmonary Drug Development
Novo Nordisk 20 March 2024, 11:21
Carterra – 24th March 2025
Stoelzle – 15th May 2025

IP Audits: A Health Check for your Intellectual Property

For most biotechnology and pharmaceutical companies, Intellectual Property (IP) is the solid foundation on which the business is built. But when was the last time that you reviewed your IP assets? Elaine Eggington at IP Pragmatics discusses how an IP audit is a valuable tool to look at each potential area of IP, including patent s, trade marks, copyright, branding and confidential know-how (trade secrets) to ensure that they are being identified and managed correctly.
 

https://international-pharma.com/wp-content/uploads/2012/12/2-IP-Audits-A-Health-Check-for-your-Intellectual-Property.pdf
Scott Pharma – 25.03.2025
Bespak – 21.05.2025
FujiFilm Skyscraper: 26th November 2024
Woolcool 26 March 2024, 16:16
Biopharma group 6 March 2024, 09:40
EyeC 18 March 2024, 13:10
Nipro – 09.06.2025
L.B. Bohle – 08.04.2025
Drug Discovery 2025, ELRIG – 04.07.2025